Tyson Kim
Chief Executive Officer at SYNTEKABIO, INC.
Tyson Kim active positions
Companies | Position | Start | End |
---|---|---|---|
SYNTEKABIO, INC. | Chief Executive Officer | 2014-12-31 | - |
Radexel Co. Ltd.
Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Chief Executive Officer | - | - |
Career history of Tyson Kim
Statistics
International
United States | 2 |
South Korea | 2 |
Operational
Chief Executive Officer | 2 |
Sectoral
Technology Services | 2 |
Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SYNTEKABIO, INC. | Technology Services |
Private companies | 1 |
---|---|
Radexel Co. Ltd.
Radexel Co. Ltd. Medical SpecialtiesHealth Technology Radexel Co. Ltd. is a medical technology company based in Seoul, KR. The company was founded in 2018 by CEO Tyson Kim on the basis of Seoul Asan Medical Center development technology. Radexel is developing a radiation therapy device that treats cancer precisely with the world's first developed magnetic-radiation fusion technology and AI treatment plan. The device reduces side effects of normal tissue adjacent to cancer and improves treatment effect. It is also low-cost and compact, and can be installed in the same space as the existing radiation therapy device. | Health Technology |
- Stock Market
- Insiders
- Tyson Kim
- Experience